BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1755576)

  • 1. Postmarketing surveillance and other epidemiologic uses of drug prescription data in the United States.
    Strom BL
    Ann Ist Super Sanita; 1991; 27(2):235-7. PubMed ID: 1755576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of different logistical approaches to postmarketing surveillance.
    Strom BL
    J Rheumatol Suppl; 1988 Oct; 17():9-13. PubMed ID: 3204621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug utilization studies within the VIDEOFAR project.
    Maggini M; Menniti Ippolito F; Spila Alegiani S; Traversa G; Fortini M
    Ann Ist Super Sanita; 1991; 27(2):201-6. PubMed ID: 1755571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VIDEOFAR: an epidemiologic tool for drug utilization studies.
    Raschetti R
    Ann Ist Super Sanita; 1991; 27(2):191-3. PubMed ID: 1755569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Information systems for the analysis of drug prescriptions in Spain.
    Ferrando MC
    Ann Ist Super Sanita; 1991; 27(2):213-6. PubMed ID: 1755573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health authorities and drug utilization studies.
    Garcia Alonso F; Scott AI; Stika L; Westerholm B
    WHO Reg Publ Eur Ser; 1993; 45():147-67. PubMed ID: 8442843
    [No Abstract]   [Full Text] [Related]  

  • 7. Reports of hyperkalemia after publication of RALES--a pharmacovigilance study.
    Hauben M; Reich L; Gerrits CM
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):775-83. PubMed ID: 16804951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of databases in drug postmarketing surveillance.
    Rodriguez EM; Staffa JA; Graham DJ
    Pharmacoepidemiol Drug Saf; 2001; 10(5):407-10. PubMed ID: 11802586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quantification of drug risks in practice.
    Lee D; Bergman U
    WHO Reg Publ Eur Ser; 1993; 45():79-95. PubMed ID: 8442852
    [No Abstract]   [Full Text] [Related]  

  • 10. Automated support for pharmacovigilance: a proposed system.
    Bright RA; Nelson RC
    Pharmacoepidemiol Drug Saf; 2002 Mar; 11(2):121-5. PubMed ID: 11998536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacovigilance in pregnancy using population-based linked datasets.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):211-25. PubMed ID: 19173342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions and reporting.
    Witte R
    Clin J Oncol Nurs; 2000; 4(4):181, 184. PubMed ID: 11261100
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of health care databases in pharmacoepidemiology.
    Hennessy S
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):311-3. PubMed ID: 16611207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risks of pharmacological therapy for insomnia (part 1): update for the clinical nurse specialist.
    O'Malley P
    Clin Nurse Spec; 2007; 21(4):188-90. PubMed ID: 17622806
    [No Abstract]   [Full Text] [Related]  

  • 15. The logical structure of the VIDEOFAR drug data base.
    Caffari B; Raschetti R
    Ann Ist Super Sanita; 1991; 27(2):195-200. PubMed ID: 1755570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A beneficial side effect of the Medicare drug benefit.
    Platt R; Ommaya A
    N Engl J Med; 2005 Dec; 353(26):2742-3. PubMed ID: 16382059
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible applications of drug prescription monitoring systems in Italy.
    Bozzini L
    Ann Ist Super Sanita; 1991; 27(2):207-11. PubMed ID: 1755572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. By the Numbers. Prescription drugs and supplies.
    Mod Healthc; 2001 Dec; 31(52 Suppl):30. PubMed ID: 11808395
    [No Abstract]   [Full Text] [Related]  

  • 20. Early detection of adverse drug events within population-based health networks: application of sequential testing methods.
    Brown JS; Kulldorff M; Chan KA; Davis RL; Graham D; Pettus PT; Andrade SE; Raebel MA; Herrinton L; Roblin D; Boudreau D; Smith D; Gurwitz JH; Gunter MJ; Platt R
    Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1275-84. PubMed ID: 17955500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.